Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.13B |
| 2 |
AT&T
T
|
+$275M |
| 3 |
Apple
AAPL
|
+$248M |
| 4 |
Walt Disney
DIS
|
+$235M |
| 5 |
Nike
NKE
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.17B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$863M |
| 4 |
Advanced Micro Devices
AMD
|
+$808M |
| 5 |
Amazon
AMZN
|
+$783M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.82% |
| 2 | Technology | 1.6% |
| 3 | Consumer Discretionary | 1.3% |
| 4 | Financials | 0.99% |
| 5 | Communication Services | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
PUT
Amplify Blockchain Technology ETF
BLOK
$1.14B
| $9.87M | ﹤0.01% |
245,800
+69,300
| +39% | +$3.61M |
|
2702
PUT
Organon & Co
OGN
$3.61B
| $9.87M | ﹤0.01% |
324,100
+74,400
| +30% | +$2.42M |
|
2703
Northern Trust
NTRS
$34.1B
| $9.86M | ﹤0.01% |
82,451
+33,794
| +69% | +$4.05M |
|
|
SAGE
2704
PUT
DELISTED
Sage Therapeutics
SAGE
| $9.86M | ﹤0.01% |
231,700
+5,500
| +2% | +$230K |
|
|
JOYY
2705
JOYY Inc
JOYY
$3.66B
| $9.84M | ﹤0.01% |
216,689
-72,932
| -25% | -$3.76M |
|
2706
PUT
Intellia Therapeutics
NTLA
$1.84B
| $9.84M | ﹤0.01% |
83,200
-77,200
| -48% | -$9.67M |
|
2707
Alaska Air
ALK
$4.71B
| $9.83M | ﹤0.01% |
188,607
+9,249
| +5% | +$501K |
|
2708
Bio-Techne
TECH
$11.4B
| $9.82M | ﹤0.01% |
75,960
+16,748
| +28% | +$2.05M |
|
2709
StoneCo
STNE
$2.2B
| $9.81M | ﹤0.01% |
582,156
-192,180
| -25% | -$4.87M |
|
2710
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.52B
| $9.8M | ﹤0.01% |
210,100
-13,200
| -6% | -$616K |
|
2711
CALL
Hyatt Hotels
H
$16.3B
| $9.79M | ﹤0.01% |
102,100
+19,900
| +24% | +$1.7M |
|
2712
PUT
Insulet
PODD
$9.95B
| $9.79M | ﹤0.01% |
36,800
-7,700
| -17% | -$2.23M |
|
2713
CALL
iShares MSCI Japan ETF
EWJ
$22.7B
| $9.78M | ﹤0.01% |
146,100
-1,034,100
| -88% | -$70.7M |
|
2714
CALL
Globus Medical
GMED
$11.1B
| $9.78M | ﹤0.01% |
135,500
+25,700
| +23% | +$1.87M |
|
2715
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.51B
| $9.78M | ﹤0.01% |
+276,680
| New | +$9.77M |
|
2716
CALL
Unilever
UL
$139B
| $9.77M | ﹤0.01% |
161,511
+67,733
| +72% | +$4.02M |
|
2717
Icahn Enterprises
IEP
$4.78B
| $9.76M | ﹤0.01% |
196,902
+60,304
| +44% | +$3.21M |
|
2718
PUT
FMC
FMC
$1.33B
| $9.76M | ﹤0.01% |
88,800
-8,700
| -9% | -$875K |
|
2719
Vanguard FTSE Emerging Markets ETF
VWO
$127B
| $9.75M | ﹤0.01% |
197,166
-247,562
| -56% | -$12.5M |
|
|
SEAH
2720
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
| $9.75M | ﹤0.01% |
983,089
-794,723
| -45% | -$8.38M |
|
2721
PUT
Smith & Wesson
SWBI
$586M
| $9.75M | ﹤0.01% |
547,600
-164,100
| -23% | -$3.39M |
|
2722
W.W. Grainger
GWW
$62.2B
| $9.75M | ﹤0.01% |
18,806
+10,581
| +129% | +$4.99M |
|
2723
CALL
Ventas
VTR
$47.6B
| $9.74M | ﹤0.01% |
190,600
-165,400
| -46% | -$8.64M |
|
2724
Inovio Pharmaceuticals
INO
$130M
| $9.74M | ﹤0.01% |
162,684
+17,172
| +12% | +$1.38M |
|
2725
CALL
Guidewire Software
GWRE
$16.7B
| $9.74M | ﹤0.01% |
85,800
+48,400
| +129% | +$5.74M |
|
Similar funds
Jeff Yass's Q4 2021 Portfolio in Review
As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
- Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
- Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
- Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
- Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
- Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
- Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.